[
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-2",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026?",
    "source": "AOL.com",
    "publishedAt": "2026-02-04T15:52:29.842Z",
    "summary": "Eli Lilly (NYSE: LLY) has been on a roll in recent years, thanks to its leadership in the weight management drug market.",
    "url": "https://www.aol.com/articles/could-acquiring-ventyx-biosciences-send-190000182.html",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTsgYuoVbAbxhJdjlZZUMFEkz7fbH4aUaINK-hjCRsP2pBCPg9tyTNMN7Q&usqp=CAI&s",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-9",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Holdings Stock Price Forecast. Should You Buy VIK?",
    "source": "stockinvest.us",
    "publishedAt": "2026-01-30T06:48:49.712Z",
    "summary": "Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.",
    "url": "https://stockinvest.us/stock/VIK",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-2",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Which companies will be acquired before 2027?",
    "source": "perplexity.ai",
    "publishedAt": "2026-01-29T08:35:42.799Z",
    "summary": "Discovery at 100%), while GitLab (51%) and Ubisoft (50%) remain coin flips with the highest active trading interest, and Viking Therapeutics (36%) presents ...",
    "url": "https://www.perplexity.ai/finance/predictions/86832",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-7",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Madrigal Pharmaceuticals, Novo Nordisk, 89bio",
    "source": "barchart.com",
    "publishedAt": "2026-01-28T23:55:03.938Z",
    "summary": "For example, Lanifibranor/IVA337 in the US is expected to be launched by 2027 with a peak share of 2.9%. HPG1860 is anticipated to take 7 years to peak with ...",
    "url": "https://www.barchart.com/story/news/37285319/nonalcoholic-steatohepatitis-market-to-evolve-rapidly-over-the-next-decade-delveinsight-observes-madrigal-pharmaceuticals-novo-nordisk-89bio",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-7",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "1 Bold Prediction for Viking Therapeutics in 2026",
    "source": "aol.com",
    "publishedAt": "2026-01-28T19:35:42.799Z",
    "summary": "Viking's pipeline may release its value next year, and larger companies are likely to consider acquiring it.",
    "url": "https://www.aol.com/articles/1-bold-prediction-viking-therapeutics-183500235.html",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-1",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics (VKTX) to Release Quarterly Earnings ...",
    "source": "marketbeat.com",
    "publishedAt": "2026-01-28T13:50:03.028Z",
    "summary": "Duquesne Family Office LLC acquired a new stake in shares of Viking Therapeutics during the second quarter worth approximately $14,556,000. Finally, Schonfeld ...",
    "url": "https://www.marketbeat.com/instant-alerts/viking-therapeutics-vktx-to-release-quarterly-earnings-on-wednesday-2026-01-28/",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-6",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Eli Lilly vs. Viking Therapeutics: The Scalability and Market ...",
    "source": "ainvest.com",
    "publishedAt": "2026-01-28T13:48:49.712Z",
    "summary": "The ultimate catalyst for Viking is not just clinical data, but a potential partnership or acquisition. With a market cap of just $3.59 billion, the company ...",
    "url": "https://www.ainvest.com/news/eli-lilly-viking-therapeutics-scalability-market-penetration-play-2601/",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-3",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "1 Biotech Stock Set to Rebound in 2026",
    "source": "aol.com",
    "publishedAt": "2026-01-28T07:58:05.549Z",
    "summary": "Two intriguing corporations to consider now are Viking Therapeutics (NASDAQ: VKTX) and BioNTech (NASDAQ: BNTX). These biotech companies are somewhat risky, but ...",
    "url": "https://www.aol.com/articles/1-biotech-stock-set-rebound-065000112.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-6",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 'Strong Buy' Growth Stocks With Upside of Around 200%",
    "source": "finance.yahoo.com",
    "publishedAt": "2026-01-28T07:55:03.938Z",
    "summary": "Growth Stock #2: Viking Therapeutics. Valued at a market cap $3.58 billion, Viking Therapeutics (VKTX) is another high-risk, high-reward growth stock in the ...",
    "url": "https://finance.yahoo.com/news/2-strong-buy-growth-stocks-210255972.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-4",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 'Strong Buy' Growth Stocks With Upside of Around 200%",
    "source": "barchart.com",
    "publishedAt": "2026-01-27T21:58:05.549Z",
    "summary": "Valued at a market cap $3.58 billion, Viking Therapeutics (VKTX) is another high-risk, high-reward growth stock in the biotech sector. It is a clinical-stage ...",
    "url": "https://www.barchart.com/story/news/37258170/2-strong-buy-growth-stocks-with-upside-of-around-200",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-7",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Growth Stock #1: Celldex Therapeutics",
    "source": "farmerswin.com",
    "publishedAt": "2026-01-27T21:58:05.549Z",
    "summary": "Valued at a market cap $3.58 billion, Viking Therapeutics (VKTX) is another high-risk, high-reward growth stock in the biotech sector. It is a clinical-stage ...",
    "url": "https://www.farmerswin.com/news/story/37258171/2-strong-buy-growth-stocks-with-upside-of-around-200",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-1",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Novo Nordisk vs. Viking: Which Obesity Drug Stock is the ...",
    "source": "nasdaq.com",
    "publishedAt": "2026-01-27T19:35:42.799Z",
    "summary": "However, from both phase III studies are not expected until 2027. Beyond VK2735, Viking Therapeutics is expanding its obesity pipeline.",
    "url": "https://www.nasdaq.com/articles/novo-nordisk-vs-viking-which-obesity-drug-stock-safer-bet",
    "sentiment": "bearish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-10",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "1 Pharmaceutical Stock Set to Rebound in 2026",
    "source": "aol.com",
    "publishedAt": "2026-01-27T19:35:42.799Z",
    "summary": "Two intriguing corporations to consider now are Viking Therapeutics (NASDAQ: VKTX) and BioNTech (NASDAQ: BNTX). These biotech companies are somewhat risky, but ...",
    "url": "https://www.aol.com/articles/1-pharmaceutical-stock-set-rebound-180000262.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-3",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 Pharmaceutical Stocks Set to Rebound in 2026",
    "source": "aol.com",
    "publishedAt": "2026-01-27T19:35:37.260Z",
    "summary": "... Viking strikes a partnership or is acquired by a larger player. This is a possibility since many pharma and biotech companies aim to get in on this ...",
    "url": "https://www.aol.com/articles/2-pharmaceutical-stocks-set-rebound-153700407.html",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-10",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "ALT Altimmune, Inc. Latest Comments",
    "source": "seekingalpha.com",
    "publishedAt": "2026-01-27T19:35:37.260Z",
    "summary": "... acquired by big pharma and get Pemvi to market in late or early 2027. ... VKTXViking Therapeutics, Inc. 31.40. Pre. 31.63. -1.04%. 0.73%. AVXLAnavex Life ...",
    "url": "https://seekingalpha.com/symbol/ALT/comments",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-5",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Novo Nordisk vs. Viking: Which Obesity Drug Stock is the ...",
    "source": "finance.yahoo.com",
    "publishedAt": "2026-01-27T19:32:30.228Z",
    "summary": "NVO and VKTX face rising competition and setbacks as investors weigh scale, pipelines and execution risks in the crowded obesity drug race.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-vs-viking-obesity-144100886.html",
    "sentiment": "bearish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-8",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Novo Nordisk vs. Viking: Which Obesity Drug Stock is ...",
    "source": "zacks.com",
    "publishedAt": "2026-01-27T19:32:30.228Z",
    "summary": "NVO and VKTX face rising competition and setbacks as investors weigh scale, pipelines and execution risks in the crowded obesity drug race.",
    "url": "https://www.zacks.com/stock/news/2823415/novo-nordisk-vs-viking-which-obesity-drug-stock-is-the-safer-bet",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-4",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics and BioNTech: Assessing Scalability ...",
    "source": "ainvest.com",
    "publishedAt": "2026-01-27T19:32:30.228Z",
    "summary": "The biotech sector is entering 2026 on a powerful upswing, creating a rare environment where scalable growth is not just possible but actively being fueled ...",
    "url": "https://www.ainvest.com/news/viking-therapeutics-biontech-assessing-scalability-2026-metabolic-health-surge-2601/",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-1",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Novo Nordisk vs. Viking: Which Obesity Drug Stock is the ...",
    "source": "sg.finance.yahoo.com",
    "publishedAt": "2026-01-27T14:32:09.394Z",
    "summary": "However, from both phase III studies are not expected until 2027. Beyond VK2735, Viking Therapeutics is expanding its obesity pipeline.",
    "url": "https://sg.finance.yahoo.com/news/novo-nordisk-vs-viking-obesity-144100886.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-9",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Top Upcoming IPOs and Recent IPOs (Updated 2026)",
    "source": "dealroom.net",
    "publishedAt": "2026-01-26T19:35:37.260Z",
    "summary": "Discover upcoming 2026 IPOs and review the most recent IPOs from 2025 and 2024 in our detailed article.",
    "url": "https://dealroom.net/blog/upcoming-recent-ipos",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-3",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Eli Lilly or Viking Therapeutics: Which Stock Is More Likely ...",
    "source": "fool.com",
    "publishedAt": "2026-01-26T19:32:30.228Z",
    "summary": "Eli Lilly and Viking Therapeutics both operate in the high-growth field of obesity drugs. This market is forecast to reach almost $100 billion by the end of the ...",
    "url": "https://www.fool.com/investing/2026/01/26/eli-lilly-or-viking-therapeutics-millionaire-maker/",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-10",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Eli Lilly or Viking Therapeutics: Which Stock Is More Likely ...",
    "source": "theglobeandmail.com",
    "publishedAt": "2026-01-26T19:32:30.228Z",
    "summary": "... Viking strikes a partnership or is acquired by a larger player. This is a possibility since many pharma and biotech companies aim to get in on this ...",
    "url": "https://www.theglobeandmail.com/investing/markets/stocks/LLY/pressreleases/37231536/eli-lilly-or-viking-therapeutics-which-stock-is-more-likely-to-be-a-millionaire-maker/",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-6",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Eli Lilly or Viking Therapeutics: Which Stock Is More Likely ...",
    "source": "theglobeandmail.com",
    "publishedAt": "2026-01-26T13:50:03.028Z",
    "summary": "... Viking strikes a partnership or is acquired by a larger player. This is a possibility since many pharma and biotech companies aim to get in on this ...",
    "url": "https://www.theglobeandmail.com/investing/markets/stocks/VKTX-Q/pressreleases/37231536/eli-lilly-or-viking-therapeutics-which-stock-is-more-likely-to-be-a-millionaire-maker/",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-4",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics Gains Momentum Amid Acquisition Chatter",
    "source": "AD HOC NEWS",
    "publishedAt": "2026-01-25T19:30:26.158Z",
    "summary": "Shares of Viking Therapeutics are capturing significant investor attention, currently trading around $33.52. While the biotech firm faces...",
    "url": "https://www.ad-hoc-news.de/boerse/ueberblick/viking-therapeutics-gains-momentum-amid-acquisition-chatter/68506234",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR0sQLbcPBSUSezrGbuCEjp50IfnAnC9Lw4SpqwLRIk8N4VGkXkkQQ__xQ&usqp=CAI&s",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-8",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics: A Stock Poised Between Pullback and ...",
    "source": "ad-hoc-news.de",
    "publishedAt": "2026-01-25T17:02:37.290Z",
    "summary": "The investment community is now awaiting further clinical readouts. While comprehensive Phase 3 results for the injectable are not expected until 2027 ...",
    "url": "https://www.ad-hoc-news.de/news/ueberblick/viking-therapeutics-a-stock-poised-between-pullback-and-promise/68517437",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-8",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Prescription Weight Loss Medications Market Size [2035]",
    "source": "astuteanalytica.com",
    "publishedAt": "2026-01-24T19:35:37.260Z",
    "summary": "If Viking is acquired by a major pharma player (Pfizer or Amgen) in 2026, this asset could rapidly scale. Amgen (MariTide / AMG 133). Amgen is playing a ...",
    "url": "https://www.astuteanalytica.com/industry-report/prescription-weight-loss-medications-market",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-8",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "What Happened to Viking Therapeutics in 2025, And ...",
    "source": "aol.com",
    "publishedAt": "2026-01-24T13:58:05.549Z",
    "summary": "Viking Therapeutics' stock was volatile in 2025 due to clinical trial results. VK2735's oral form faced safety concerns but remains promising. Viking could be ...",
    "url": "https://www.aol.com/finance/happened-viking-therapeutics-2025-buy-202512839.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-xpost-2015047066104295477",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "This 1969 Rover 2000 TC is a non-running project that was acquired by the selling dealer out of long-term storage in the...",
    "source": "@Bringatrailer",
    "publishedAt": "2026-01-24T13:00:32.000Z",
    "summary": "This 1969 Rover 2000 TC is a non-running project that was acquired by the selling dealer out of long-term storage in the Hamptons on New York’s Long Island in December 2025. It's listed now with no reserve on BaT! \n\nhttps://t.co/LEC7HZcddu https://t.co/XHxpWAu29V",
    "url": "https://x.com/Bringatrailer/status/2015047066104295477",
    "sentiment": "neutral",
    "impactScore": 3,
    "sourceType": "x"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-9",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics (VKTX) 2026 Deep Dive - FinancialContent",
    "source": "markets.financialcontent.com",
    "publishedAt": "2026-01-23T19:35:42.799Z",
    "summary": "With a current burn rate driven by the massive Phase 3 VANQUISH trials, Viking has a cash runway extending into late 2026 or early 2027. This provides the ...",
    "url": "https://markets.financialcontent.com/stocks/article/finterra-2026-1-23-viking-therapeutics-vktx-2026-deep-dive-challenging-the-obesity-duopoly",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-3",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics: A Stock at a Crossroads",
    "source": "ad-hoc-news.de",
    "publishedAt": "2026-01-23T19:32:09.394Z",
    "summary": "However, final results from the Phase 3 program are not anticipated until 2027, pushing the horizon for any potential regulatory decisions further into the ...",
    "url": "https://www.ad-hoc-news.de/boerse/ueberblick/viking-therapeutics-a-stock-at-a-crossroads/68512879",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-5",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics (VKTX) 2026 Deep Dive: Challenging the ...",
    "source": "markets.chroniclejournal.com",
    "publishedAt": "2026-01-23T19:32:09.394Z",
    "summary": "With a current burn rate driven by the massive Phase 3 VANQUISH trials, Viking has a cash runway extending into late 2026 or early 2027. This provides the ...",
    "url": "http://markets.chroniclejournal.com/chroniclejournal/article/finterra-2026-1-23-viking-therapeutics-vktx-2026-deep-dive-challenging-the-obesity-duopoly",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-6",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Big Tech Predictions & Real-Time Odds",
    "source": "polymarket.com",
    "publishedAt": "2026-01-22T17:02:37.290Z",
    "summary": "Which companies will be acquired before 2027? $78.7k Vol. $6.6k Liq. 2. Ends in 11 months. 52%. Viking Therapeutics ... Who will close Warner Bros. acquisition ...",
    "url": "https://polymarket.com/nl/predictions/big-tech",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-10",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics (NASDAQ:VKTX) Downgraded by ...",
    "source": "marketbeat.com",
    "publishedAt": "2026-01-22T13:50:03.028Z",
    "summary": "Lodestone Wealth Management LLC acquired a new position in Viking Therapeutics in the fourth quarter valued at $39,000. Finally, Elevation Point Wealth Partners ...",
    "url": "https://www.marketbeat.com/instant-alerts/viking-therapeutics-nasdaqvktx-downgraded-by-zacks-research-to-strong-sell-2026-01-22/",
    "sentiment": "bearish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-10",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "ABBV vs. MRK: An Oncology-Immunology Showdown for ...",
    "source": "finviz.com",
    "publishedAt": "2026-01-22T07:55:03.938Z",
    "summary": "Merck has been on an acquisition spree in the past year, as it faces the looming patent expiration of Keytruda in 2028. Earlier this month, it closed the ...",
    "url": "https://finviz.com/news/284278/abbv-vs-mrk-an-oncology-immunology-showdown-for-investors",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-4",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 Bargain Stocks You Can Buy for Less Than $100 Right ...",
    "source": "finviz.com",
    "publishedAt": "2026-01-22T07:45:56.259Z",
    "summary": "Shares of healthcare stock Viking Therapeutics finished last week at just under $34. Its market cap is $3.8 billion, and its return over the past 12 months has ...",
    "url": "https://finviz.com/news/282914/2-bargain-stocks-you-can-buy-for-less-than-100-right-now",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-8",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 Bargain Stocks You Can Buy for Less Than $100 Right ...",
    "source": "fool.com",
    "publishedAt": "2026-01-22T07:45:56.259Z",
    "summary": "What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ... The Motley Fool recommends Viking Therapeutics and recommends the following options: ...",
    "url": "https://www.fool.com/investing/2026/01/21/2-bargain-stocks-you-can-buy-for-less-than-100-rig/",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-7",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 Bargain Stocks You Can Buy for Less Than $100 Right ...",
    "source": "nasdaq.com",
    "publishedAt": "2026-01-21T19:32:30.228Z",
    "summary": "The Motley Fool recommends Viking Therapeutics and recommends the following options: long January 2027 $42.50 calls on PayPal and short March 2026 $65 calls on ...",
    "url": "https://www.nasdaq.com/articles/2-bargain-stocks-you-can-buy-less-100-right-now",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-10",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "1 Stock That Could Soar by 175%, According to Wall Street",
    "source": "aol.com",
    "publishedAt": "2026-01-21T19:32:09.394Z",
    "summary": "So, even if this maintenance study goes well, it won't help Viking's shares more than double this year. And phase 3 data for VK2735 might not come until 2027 ...",
    "url": "https://www.aol.com/articles/1-stock-could-soar-175-155000237.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-7",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Acquisitions Predictions & Real-Time Odds",
    "source": "polymarket.com",
    "publishedAt": "2026-01-21T19:32:09.394Z",
    "summary": "Which companies will be acquired before 2027? $45.9k Volyymi. $6.5k Liq. 2. Ends in 11 months. 53%. Viking Therapeutics. $45.9k Volyymi. $6.5k Liq. 2. Ends in ...",
    "url": "https://polymarket.com/fi/predictions/acquisitions",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-4",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 Bargain Stocks You Can Buy for Less Than $100 Right ...",
    "source": "finance.yahoo.com",
    "publishedAt": "2026-01-21T17:02:37.290Z",
    "summary": "Shares of healthcare stock Viking Therapeutics finished last week at just under $34. Its market cap is $3.8 billion, and its return over the past 12 months has ...",
    "url": "https://finance.yahoo.com/news/2-bargain-stocks-buy-less-204100938.html",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-5",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "2 Bargain Stocks You Can Buy for Less Than $100 Right ...",
    "source": "theglobeandmail.com",
    "publishedAt": "2026-01-21T13:58:05.549Z",
    "summary": "Shares of healthcare stock Viking Therapeutics finished last week at just under $34. Its market cap is $3.8 billion, and its return over the past 12 months has ...",
    "url": "https://www.theglobeandmail.com/investing/markets/stocks/PYPL/pressreleases/37159670/2-bargain-stocks-you-can-buy-for-less-than-100-right-now/",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-xpost-2013676652081950845",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Kris Knoblauch confirms that Tristan Jarry will get the start tonight vs. New Jersey. It will be his first start at Roge...",
    "source": "@paigymartin",
    "publishedAt": "2026-01-20T18:15:00.000Z",
    "summary": "Kris Knoblauch confirms that Tristan Jarry will get the start tonight vs. New Jersey. It will be his first start at Rogers Place since being acquired in December #Oilers",
    "url": "https://x.com/paigymartin/status/2013676652081950845",
    "sentiment": "neutral",
    "impactScore": 4,
    "sourceType": "x"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-0",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026?",
    "source": "The Motley Fool",
    "publishedAt": "2026-01-18T13:41:18.622Z",
    "summary": "Investors in biotechnology company Viking Therapeutics (VKTX +8.18%) had a rollercoaster ride in 2025, driven by clinical trial data,...",
    "url": "https://www.fool.com/investing/2026/01/20/what-happened-to-viking-therapeutics-in-2025-and-i/",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQimLjoZrM2E8ItEGKrIXkuXvSH1D_RyQUpooLM7HKU7B-FEBjZPskSYtw&usqp=CAI&s",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-5",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Big Pharma enters 2026 with an appetite for deals",
    "source": "Sherwood News",
    "publishedAt": "2026-01-18T13:41:18.622Z",
    "summary": "At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they're primed for M&A this year, after a big year for deals in 2025...",
    "url": "https://sherwood.news/business/big-pharma-enters-2026-with-an-appetite-for-deals/",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTkhl3vo0j5TuLAwlG22fX0RYAumg57FbQ74ZJvVRCJz8wZXjHtVIr8SWY&usqp=CAI&s",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-1",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Appetite for weight-loss deals broader than visible, Viking CEO says",
    "source": "Reuters",
    "publishedAt": "2026-01-17T07:31:22.781Z",
    "summary": "Weight-loss drug developer Viking Therapeutics CEO said on Monday that strategic interest in weight-loss drug deals is broader than it...",
    "url": "https://www.reuters.com/business/healthcare-pharmaceuticals/appetite-weight-loss-deals-broader-than-visible-viking-ceo-says-2026-01-13/",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRP7ieSu8I2kNdjMWUlfSq8e8lrzOWe0zaLFg39GKs-Fx8JJQ2a2y139gk&usqp=CAI&s",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-9",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics stock jumps 11% as CEO flags broader appetite for obesity-drug deals",
    "source": "TechStock²",
    "publishedAt": "2026-01-17T07:31:22.781Z",
    "summary": "New York, January 14, 2026, 13:09 EST — Regular session underway. Shares of Viking Therapeutics jumped roughly 11% in midday trading amid...",
    "url": "https://ts2.tech/en/viking-therapeutics-stock-jumps-11-as-ceo-flags-broader-appetite-for-obesity-drug-deals/",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTRzQ34Sc2ic-sK1KbfAVuf53ajnIDWN3QHgCuCPVmiJwlH2iGFy9UAU_4&usqp=CAI&s",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-4",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking enlists commercial chief to battle obesity giants, while Aspen names CCO to prep for Parkinson's launch",
    "source": "Fierce Pharma",
    "publishedAt": "2026-01-08T13:41:18.622Z",
    "summary": "Viking Therapeutics and Aspen Neuroscience have tapped commercial leaders with resumes spanning the likes of Amgen, Eli Lilly, Merck and...",
    "url": "https://www.fiercepharma.com/marketing/viking-enlists-commercial-chief-battle-obesity-giants",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS5OnOf6_e9QCdQt6aiJ1a7YlhVa-bJlhstW3hpxZl_k9GJI1gk98BP2KI&usqp=CAI&s",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-8",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "6 Biotechs That Could Be Big Pharma’s Next M&A Target",
    "source": "BioSpace",
    "publishedAt": "2026-01-08T13:41:18.622Z",
    "summary": "With M&A back on the table after a dramatic bidding war for Metsera, analysts are searching for clues as to what biotech will be the next...",
    "url": "https://www.biospace.com/business/6-biotechs-that-could-be-big-pharmas-next-m-a-target",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQwVm3h9Vfo0Vox_k40RUR71PE_gEVyvjO4hYzq2lNuFJ4POaPd2GWCrDg&usqp=CAI&s",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-3",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "VKTX Completes Enrollment in Phase I Maintenance Study of Obesity Drug",
    "source": "TradingView",
    "publishedAt": "2026-01-08T07:38:06.997Z",
    "summary": "Viking Therapeutics VKTX announced that it has completed enrolling patients in its exploratory maintenance dosing study of VK2735,...",
    "url": "https://www.tradingview.com/news/zacks:38b798a0d094b:0-vktx-completes-enrollment-in-phase-i-maintenance-study-of-obesity-drug/",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRnVwwa3qw6JFx1ZTVtC8E3DJ7tpXkeH_veh4zQ034ftetQ22O4UGi0HIY&usqp=CAI&s",
    "sentiment": "bullish",
    "impactScore": 7,
    "sourceType": "news"
  },
  {
    "id": "will-viking-therapeutics-be-acquired-before-2027-542-serper-9",
    "marketId": "will-viking-therapeutics-be-acquired-before-2027-542",
    "title": "Viking Therapeutics' Swing Trade Potential Emerges - Competition/Dilution Risks Remain (NASDAQ:VKTX)",
    "source": "Seeking Alpha",
    "publishedAt": "2026-01-06T07:41:54.420Z",
    "summary": "VKTX remains a Buy for its cheap FY2030 EV/Sales valuations of 2.28x, the strong clinical trial results exceeding legacy players,...",
    "url": "https://seekingalpha.com/article/4856043-viking-therapeutics-swing-trade-potential-emerges-competitiondilution-risks-remain",
    "imageUrl": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR-GSZGa02DJybDCgDVxDMEuxGzZ9s5xcwAHhAHIfpOV-aVPxTVZwVQcGs&usqp=CAI&s",
    "sentiment": "neutral",
    "impactScore": 5,
    "sourceType": "news"
  }
]